LIMITATIONS OF CA125 IN THE PREOPERATIVE EVALUATION OF A PELVIC MASS - STRUMA OVARII AND ASCITES

被引：21

作者：

LEUNG, YC ^{[1
]}

HAMMOND, IG ^{[1
]}

机构：

[1] KING EDWARD MEM HOSP WOMEN,374 BAGOT RD,SUBIACO,WA 6008,AUSTRALIA

来源：

AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY | 1993年 / 33卷 / 02期

关键词：

D O I：

10.1111/j.1479-828X.1993.tb02400.x

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

This report discusses the limitations of using the serum tumour marker CA 125 in the preoperative evaluation of a woman presenting with a pelvic mass. We present 2 cases of benign struma ovarii which were associated with elevated levels of CA 125.

引用

页码：216 / 217

页数：2

共 7 条

[1]

Bast RC, Freeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC, Reactivity of a monoclonal antibody with human ovarian cancer, J Clin Investig, 68, pp. 1331-1337, (1981)

[2]

Niloff JM, Knapp RC, Schaetzl E, Zurawski VR, Reynolds C, Bast RC, CA 125 antigen levels in obstetric and gynecologic patients, Obstet Gynaecol, 64, pp. 703-707, (1984)

[3]

Bast RC, Knapp RC, Letter N Engl J Med, 301, pp. 724-725, (1984)

[4]

Williams LL, Fleischer AC, Jones HW, Transvaginal color Doppler sonography and CA 125 elevation in a patient with ovarian thecoma and ascites, Gynaecologic Oncology, 46, pp. 115-118, (1992)

[5]

OConnell GJ, Ryan E, Murphy KJ, Prefontaine M., Predictive value of CA 125 for ovarian carcinoma in patients with pelvic masses, Obstet Gynecol, 70, pp. 930-932, (1987)

[6]

Bourne T, Campbell S, Steer C, Whitehead, Collins WP, Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer, BMJ, 299, pp. 1367-1370, (1989)

[7]

Bast RC, Klug TL, St John E, Et al., A radioimmunoassay using monoclonal antibody to monitor the course of epithelial ovarian cancer, N Engl J Med, 309, pp. 883-887, (1983)

← 1 →